Patients with myeloproliferative neoplasms and COVID‐19 have increased rates of arterial thrombosis

BACKGROUND: Both coronavirus disease‐2019 (COVID‐19) and myeloproliferative neoplasms (MPNs) are associated with systemic inflammation and risk of thrombosis. Risk of thrombosis in patients with COVID with and without MPNs has not been extensively studied. METHODS: Retrospective cohort study of 44 p...

Descripción completa

Detalles Bibliográficos
Autores principales: Leiva, Orly, Campia, Umberto, Snyder, Julia, Barns, Briana M., Rizzo, Samantha, Khairani, Candrika D., Brunner, Andrew, Al‐Samkari, Hanny, Leaf, Rebecca Karp, Rosovsky, Rachel, Goodarzi, Katayoon, Bornikova, Larissa, Fathi, Amir, Goldhaber, Samuel Z., Hobbs, Gabriela, Piazza, Gregory
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372283/
https://www.ncbi.nlm.nih.gov/pubmed/35979196
http://dx.doi.org/10.1002/rth2.12752

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372283/
https://www.ncbi.nlm.nih.gov/pubmed/35979196
http://dx.doi.org/10.1002/rth2.12752

Ejemplares similares